Cerity Partners
PFE icon

Cerity Partners’s Pfizer PFE Stock Holding History

Cerity Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47.7M Sell
1,698,192
-1,489,263
-47% -$39.6M 0.07% 249
2025
Q4 		$79.4M Buy
3,187,455
+1,448,806
+83% +$36.5M 0.12% 165
2025
Q3 		$44.3M Sell
1,738,649
-97,684
-5% -$2.41M 0.07% 224
2025
Q2 		$44.5M Sell
1,836,333
-35,334
-2% -$824K 0.08% 210
2025
Q1 		$47.4M Sell
1,871,667
-26,670
-1% -$698K 0.1% 190
2024
Q4 		$51.9M Sell
1,898,337
-85,679
-4% -$2.32M 0.11% 168
2024
Q3 		$57.4M Buy
1,984,016
+412,364
+26% +$12M 0.13% 161
2024
Q2 		$44M Sell
1,571,652
-505,383
-24% -$13.9M 0.12% 163
2024
Q1 		$57M Buy
2,077,035
+605,691
+41% +$16.8M 0.15% 140
2023
Q4 		$42.4M Buy
1,471,344
+238,611
+19% +$7.21M 0.14% 146
2023
Q3 		$40.9M Sell
1,232,733
-306,198
-20% -$10.8M 0.2% 123
2023
Q2 		$56.4M Buy
1,538,931
+168,380
+12% +$6.55M 0.22% 106
2023
Q1 		$72.7M Buy
1,370,551
+250,559
+22% +$10.8M 0.17% 89
2022
Q4 		$58.2M Buy
1,119,992
+633,897
+130% +$30.4M 0.37% 66
2022
Q3 		$21.3M Sell
486,095
-3,488
-0.7% -$169K 0.26% 81
2022
Q2 		$25.7M Buy
489,583
+266,486
+119% +$13.6M 0.28% 72
2022
Q1 		$10.9M Buy
223,097
+13,658
+7% +$709K 0.17% 115
2021
Q4 		$11.7M Buy
209,439
+44,295
+27% +$2.19M 0.18% 108
2021
Q3 		$7.1M Sell
165,144
-9,137
-5% -$405K 0.16% 128
2021
Q2 		$6.83M Sell
174,281
-666
-0.4% -$25.9K 0.15% 129
2021
Q1 		$6.34M Sell
174,947
-64,350
-27% -$2.28M 0.15% 132
2020
Q4 		$8.81M Buy
239,297
+43,428
+22% +$1.59M 0.28% 79
2020
Q3 		$6.82M Sell
195,869
-85,322
-30% -$2.99M 0.28% 75
2020
Q2 		$8.72M Buy
281,191
+1,100
+0.4% +$37.4K 0.48% 42
2020
Q1 		$8.67M Buy
280,091
+3,540
+1% +$121K 0.55% 35
2019
Q4 		$10.3M Sell
276,551
-10,540
-4% -$375K 0.52% 37
2019
Q3 		$9.79M Buy
287,091
+640
+0.2% +$23.3K 0.57% 40
2019
Q2 		$11.8M Buy
286,451
+174,215
+155% +$6.92M 0.74% 28
2019
Q1 		$4.52M Sell
112,236
-3,896
-3% -$156K 0.3% 70
2018
Q4 		$4.81M Sell
116,132
-3,889
-3% -$161K 0.32% 69
2018
Q3 		$5.02M Sell
120,021
-2,148
-2% -$82.7K 0.35% 70
2018
Q2 		$4.21M Sell
122,169
-143,734
-54% -$4.91M 0.31% 78
2018
Q1 		$8.95M Buy
265,903
+4,927
+2% +$169K 0.68% 29
2017
Q4 		$8.97M Buy
260,976
+9,864
+4% +$336K 0.6% 33
2017
Q3 		$8.51M Buy
251,112
+160,772
+178% +$5.17M 0.6% 32
2017
Q2 		$9.9M Sell
90,340
-21,743
-19% -$686K 0.83% 20
2017
Q1 		$3.64M Buy
112,083
+105,336
+1,561% +$3.32M 0.3% 67
2016
Q4 		$208K Buy
+6,747
New +$206K 0.29% 49

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Cerity Partners's PFE Position: Q1 2026 in Review

Cerity Partners reduced its Pfizer (PFE) stake by 47% in Q1 2026, selling an estimated $39.6M and leaving 1,698,192 shares worth $47.7M. The position accounts for 0.07% of the portfolio, ranked #249.

Cerity Partners first reported a position in PFE in Q4 2016 and has held it in 38 quarters since. The position peaked at $79.4M in Q4 2025. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Cerity Partners held 1,698,192 shares of Pfizer worth $47.7M as of Q1 2026.
  • Cerity Partners sold 1,489,263 Pfizer shares in Q1 2026, an estimated $39.6M.
  • Pfizer made up 0.07% of Cerity Partners's portfolio in Q1 2026, its #249 holding.
  • Cerity Partners first reported a position in Pfizer in Q4 2016 and has held it in 38 quarters since.
  • Cerity Partners's Pfizer position peaked at $79.4M in Q4 2025.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.